IBDEI1OA ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28419,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,28419,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,28420,0)
 ;;=E53.8^^112^1421^30
 ;;^UTILITY(U,$J,358.3,28420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28420,1,3,0)
 ;;=3^Vitamin B Deficiency NEC
 ;;^UTILITY(U,$J,358.3,28420,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,28420,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,28421,0)
 ;;=E78.0^^112^1421^29
 ;;^UTILITY(U,$J,358.3,28421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28421,1,3,0)
 ;;=3^Pure Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,28421,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,28421,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,28422,0)
 ;;=E78.5^^112^1421^24
 ;;^UTILITY(U,$J,358.3,28422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28422,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,28422,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,28422,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,28423,0)
 ;;=E66.01^^112^1421^27
 ;;^UTILITY(U,$J,358.3,28423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28423,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,28423,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,28423,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,28424,0)
 ;;=D64.9^^112^1421^5
 ;;^UTILITY(U,$J,358.3,28424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28424,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,28424,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,28424,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,28425,0)
 ;;=D68.318^^112^1421^23
 ;;^UTILITY(U,$J,358.3,28425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28425,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag/Antibodies/Inhibitors
 ;;^UTILITY(U,$J,358.3,28425,1,4,0)
 ;;=4^D68.318
 ;;^UTILITY(U,$J,358.3,28425,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,28426,0)
 ;;=D50.9^^112^1421^26
 ;;^UTILITY(U,$J,358.3,28426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28426,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,28426,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,28426,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,28427,0)
 ;;=D64.81^^112^1421^2
 ;;^UTILITY(U,$J,358.3,28427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28427,1,3,0)
 ;;=3^Anemia d/t Antineoplastic Chemotherapy
 ;;^UTILITY(U,$J,358.3,28427,1,4,0)
 ;;=4^D64.81
 ;;^UTILITY(U,$J,358.3,28427,2)
 ;;=^5002349
 ;;^UTILITY(U,$J,358.3,28428,0)
 ;;=D63.1^^112^1421^4
 ;;^UTILITY(U,$J,358.3,28428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28428,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,28428,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,28428,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,28429,0)
 ;;=D62.^^112^1421^1
 ;;^UTILITY(U,$J,358.3,28429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28429,1,3,0)
 ;;=3^Acute Blood Loss Anemia
 ;;^UTILITY(U,$J,358.3,28429,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,28429,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,28430,0)
 ;;=D51.9^^112^1421^32
 ;;^UTILITY(U,$J,358.3,28430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28430,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,28430,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,28430,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,28431,0)
 ;;=D51.3^^112^1421^31
 ;;^UTILITY(U,$J,358.3,28431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28431,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Dietary
 ;;^UTILITY(U,$J,358.3,28431,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,28431,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,28432,0)
 ;;=D51.0^^112^1421^28
 ;;^UTILITY(U,$J,358.3,28432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28432,1,3,0)
 ;;=3^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,28432,1,4,0)
 ;;=4^D51.0
